- States with the most, least for-profit hospitals
- 8 recent hospital, health system CEO moves
- Why can’t this surgical risk calculator integrate with Epic?
- CVS Caremark, FTC settle insulin pricing case for $13B
- When every answer sounds right: Why clinical intelligence needs a validation layer
- White House launches AI clearinghouse to speed hospital cyber patching
- 8 recent RCM company M&A moves
- Big ideas to fix hospital revenue leakage from 25 leaders
- 19 recent health system CIO moves
- OpenAI, Apple clash over physical AI as healthcare stakes grow
- How better data has built supply chain resilience and 4 more updates
- Smile Doctors secures $125M in capital, closes in on 600 practices
- Tennessee orthopedic practice debuts new campus, future ASC
- OpenAI’s health AI chief: ‘Bet on the models getting better’
- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Full-body scan startup Neko Health scores $700M to break into the U.S. market
- Elevance Health's stock slides premarket even as it beats the Street with $1.5B in Q2 profit
- Sanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
- Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
- This psychiatric hospital CEO wants to retire the term ‘co-occurring’
- Physician assistant median pay hits $135K: State-by-state breakdown
- CHOP increased naloxone co-prescribing from 3% to 84%: Study
- CMS floats 1.68% cut to physician fee schedule, 7 other things to know
- Orthopedic robotics company lands up to $65M in growth capital
- New York awards $6.3M for mental health clubhouses
- Smile Partners USA continues de novo strategy with new practice
- 988 crisis line tops 23M contacts since launch: 5 things to know
- Bipartisan Senate bill targets ASC Medicare reimbursement gap
- Outpatient care to grow 3x faster than inpatient: Report
- Average gross billings for owner dentists surpassed $1M in 2025
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Specialty Dental Brands selects Videa as its AI platform
- States with the most, fewer psychologists per capita
- Oregon State Hospital named in wrongful death lawsuit
- Mobile care DSO Smile America Partners acquired by investment firm
- Judi Health rebrands PBM arm as Judi Rx, unveils Judi Care unit
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- The specialties winning ASC procedure access — and losing on payment
- Anthropic pushes deeper into healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- Are ASCs still the right investment? 3 orthopedic surgeons make the case
- What physicians miss when selling their ASC
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- FDA issues psychedelic drug clinical trial guidance: 8 things to know
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- Rising Tide Dental Partners expands network by 22%, appoints COO
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- HCA Healthcare now expects ACA exchange impacts to exceed $1B in 2026
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Why policy gaps threaten behavioral health coverage
- Specialty dentist pay vs. cost of living by state
- HHS, VA sign agreement to advance psychedelic therapy
- What the de novo boom means for DSOs
- Pearl vs. Videa vs. Overjet: what 3 AI giants have accomplished in 2026
- 8 dental Medicaid updates for dentists to know
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Hospital M&A stays hot in Q2 as health systems position for the future
- 13 behavioral health services, facility closures | 2026
- Cottage Health Expands Partnership with hellocare.ai Following Successful Pilot to Deploy AI Assisted Virtual Care and Patient Safety Platform Enterprise Wide
- North Carolina budget allocates millions for first-ever Rural Emergency Hospital reopening
- Payer-backed ad campaign urges lawmakers to reject NSA enforcement bill
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Insurers set to pay out $759M in 2026 MLR rebates: KFF
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- Germany pushes through healthcare reform package despite pharma's drug discount resistance
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- A New Option for Long-Term Care Costs
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
- Regulatory tracker: Eisai, Biogen scoop up subQ Leqembi starter dose nod
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
CCHFreedom reports the FDA trial no one else wants to touch in the US Court of Appeals for the Fifth Circuit in Louisiana.
From this week's newsletter.
Curious to know if these plaintifs are part of Front Line Docs.
FDA on Trial for Deadly Ivermectin Lies
FDA Claims Scientific Evidence Not Required to Make “Scientific” Claims
The FDA is rightly on trial for their deadly actions related to ivermectin. This quick 49-minute court hearing on August 8, 2023 — Apter vs. HHS, filed by Drs. Apter, Bowden, and Marik — was instructive and astonishing.
Several times, the judges had to insist that the FDA’s attorney, Ashley Cheung Honold, answer a question rather than obfuscate.
As Jared Kelson, the attorney for the three physicians (plaintiffs) said, “The fundamental issue in this case is straight forward.” He noted that nearly 40% of prescriptions prescribed in the U.S. are for off-label use and said: “After the FDA approves a human drug for sale, does it then have authority to influence or interfere with how the drug is used within the patient-doctor relationship? The answer is no.” He further stated that Congress prohibited it.
But the FDA’s attorney, who carefully referred only to ivermectin for animals as though that will exempt them from the impact their statements had on availability of ivermectin for humans, made several astonishing claims:
JUST HAVING FUN: The FDA’s “You’re not a horse…Stop it” tweet was “merely quips.”
NOT A COMMAND: “In some contexts those words could be construed as a command, but in this context where FDA was simply using these words as a quippy tweet meant to share its information article, those words do not rise to the level of a command.”
NO SCIENTIFIC PROCESS: Regularly claimed to the judges that scientific analysis of ivermectin had been performed but then admitted, “I don’t think there’s anything in the record that specifically tracked FDA’s process.”
NOT YOUR BUSINESS: “It’s not the role of the court to police the statements of an agency charged by Congress with making sure that drugs are safe or effective.” [Since ivermectin is safe and effective, why not say so?]
ROGUE: When challenged about the FDA’s authority to give its views, whether scientifically tested or not, “There’s nothing in the multiple sources of authority that I’ve cited that require FDA to go through any formal process.”
MEDICAL ADVICE: “No, your honor, the government is not conceding [that it cannot give medical advice]…It is not only permissible, but it is imperative that the FDA be able to inform the public about their scientific view about safe uses of drugs.”
WE HAD NOTHING TO DO WITH IT: When asked if FDA had obligation to speak up when hearing that hospitals and pharmacies were denying ivermectin based on FDA’s statements: “No, your honor, those hospitals and pharmacies are sophisticated independent third parties who are not controlled by the FDA.”
COURT HAVE NO ROLE: When asked who should hold FDA accountable if courts can’t: “The public can elect its government officials and FDA like other government agencies have politically accountable heads of the agency who are held accountable by the political process. It’s not the role of the courts to fact-check the FDA’s scientific statements meant to further their mission to protect the public from dangerous use of this drug.”
If the judges’ questions are any indication, the physicians will win in this case. Stay tuned. I expect this case to be appealed, whatever the decision. To hear the FDA’s attorney making these audacious claims of authority and innocence, start at the 17:30 minute mark.Good News on Ivermectin Safety
The FDA knew how safe ivermectin was. And now, a first-ever study verifies thesafety of ivermectin. An April 2023 study of ivermectin poisoning out of Cameroon found that a young woman trying to commit suicide took 400 pills of ivermectin (3 mg/each), which is about 100 times the recommended dose. Her neurological and gastric symptoms were treated at the hospital for five days and she was released. She has passed the baccalaureate test and entered the university.
Full newsletter, internal link to the trial video, and more information about CCHF here.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























